Effects of synthetic colloids on oxidative stress and inflammatory response in hemorrhagic shock: Comparison of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Chen, Gan ^a   You, Guoxing ^a   Wang, Ying ^a   Lu, Mingzi ^a   Cheng, Weina ^b   Yang, Jing ^a   Zhao, Lian ^a   Zhou, Hong ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b YANSHAN UNIVERSITY   (China)

Author keywords

Fluid resuscitation; Hemorrhagic shock; Hydroxyethyl starch; Inflammatory response; Multiple organ failure; Oxidative stress

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; GELATIN SUCCINATE; HETASTARCH; INTERLEUKIN 6; MALONALDEHYDE; MYELOPEROXIDASE; PENTOBARBITAL; TUMOR NECROSIS FACTOR ALPHA; COLLOID; GELATIN; HETASTARCH DERIVATIVE; HYDROXYETHYLSTARCH 200; PEROXIDASE; SUCCINIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; BRAIN; COLLOID; CONTROLLED STUDY; ENZYME ACTIVITY; FLUID RESUSCITATION; HEMORRHAGIC SHOCK; INFLAMMATION; INTESTINE; LIVER; LUNG; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RESUSCITATION; WISTAR RAT; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD GAS ANALYSIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; LIPID PEROXIDATION; METABOLISM; NEUTROPHIL; SHOCK, HEMORRHAGIC;

ANIMALS; BLOOD GAS ANALYSIS; COLLOIDS; DISEASE MODELS, ANIMAL; GELATIN; HYDROXYETHYL STARCH DERIVATIVES; INFLAMMATION; INTERLEUKIN-6; INTESTINES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NEUTROPHILS; OXIDATIVE STRESS; PEROXIDASE; RATS, WISTAR; SHOCK, HEMORRHAGIC; SUCCINATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880018883     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12820     Document Type: Article

References (56)

1. Alam HB, Rhee P. New developments in fluid resuscitation. Surg Clin North Am 2007, 87:55-72. 10.1016/j.suc.2006.09.015, 17127123.
2. Alam HB. An update on fluid resuscitation. Scand J Surg 2006, 95:136-145.
3. Gill R, Ruan XC, Menzel CL, Namkoong S, Loughran P, Hackam DJ, Billiar TR. Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells. Shock 2011, 35:164-170. 10.1097/SHK.0b013e3181eddcab, 3000874, 20577143.
4. Dewar D, Moore FA, Moore EE, Balogh Z. Postinjury multiple organ failure. Injury 2009, 40:912-918. 10.1016/j.injury.2009.05.024, 19541301.
5. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury 2007, 38:1336-1345. 10.1016/j.injury.2007.10.003, 18048040.
6. Fink MP. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution. Curr Opin Clin Nutr Metab Care 2002, 5:167-174. 10.1097/00075197-200203000-00009, 11844984.
7. Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, Peterson VM. Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma 1995, 39:411-417.
8. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001, 94:1133-1138. 10.1097/00000542-200106000-00030, 11465607.
9. Inoue Y, Chen Y, Pauzenberger R, Hirsh MI, Junger WG. Hypertonic saline up-regulates A3 adenosine receptor expression of activated neutrophils and increases acute lung injury after sepsis. Crit Care Med 2008, 36:2569-2575. 10.1097/CCM.0b013e3181841a91, 2643471, 18679117.
10. Alam HB, Stanton K, Koustova E, Burris D, Rich N, Rhee P. Effect of different resuscitation strategies on neutrophil activation in a swine model of hemorrhagic shock. Resuscitation 2004, 60:91-99. 10.1016/j.resuscitation.2003.08.006, 14987788.
11. Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, Bauer M, Settmacher U, Hekmat K, Hartog CS. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison. Crit Care Med 2011, 39:1335-1342. 10.1097/CCM.0b013e318212096a, 21358396.
12. Schortgen F, Deye N, Brochard L, Grp CS. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 2004, 30:2222-2229. 10.1007/s00134-004-2415-1, 15452693.
13. Majde JA. Animal models for hemorrhage and resuscitation research. J Trauma 2003, 54:S100-105.
14. Persson J, Grände PO. Volume expansion of albumin, gelatin, hydroxyethyl starch, saline and erythrocytes after haemorrhage in the rat. Intensive Care Med 2005, 31:296-301. 10.1007/s00134-004-2510-3, 15609019.
15. Dieterich HJ, Weissmuller T, Rosenberger P, Eltzschig HK. Effect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxia. Crit Care Med 2006, 34:1775-1782. 10.1097/01.CCM.0000218814.77568.BC, 16625120.
16. Zhao L, Wang B, You GX, Wang ZL, Zhou H. Effects of different resuscitation fluids on the rheologic behavior of red blood cells, blood viscosity and plasma viscosity in experimental hemorrhagic shock. Resuscitation 2009, 80:253-258. 10.1016/j.resuscitation.2008.10.014, 19059694.
17. Lee CC, Chang IJ, Yen ZS, Hsu CY, Chen SY, Su CP, Chiang WC, Chen SC, Chen WJ. Effect of different resuscitation fluids on cytokine response in a rat model of hemorrhagic shock. Shock 2005, 24:177-181. 10.1097/01.shk.0000171870.42900.15, 16044090.
18. Santry HP, Alam HB. Fluid resuscitation: past, present, and the future. Shock 2010, 33:229-241. 10.1097/SHK.0b013e3181c30f0c, 20160609.
19. Rhee P, Burris D, Kaufmann C, Pikoulis M, Austin B, Ling G, Harviel D, Waxman K. Lactated Ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock. J Trauma 1998, 44:313-319. 10.1097/00005373-199802000-00014, 9498503.
20. Ickx BE, Bepperling F, Melot C, Schulman C, Van der Linden PJ. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth 2003, 91:196-202. 10.1093/bja/aeg159, 12878617.
21. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008, 107:382-390. 10.1213/ane.0b013e31817e6eac, 18633012.
22. Shi XY, Zou Z, He XY, Xu HT, Yuan HB, Liu H. Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials. Eur J Clin Pharmacol 2011, 67:767-782. 10.1007/s00228-011-1008-5, 21365330.
23. Chen G, Yan M, Lu QH, Gong M. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein. Acta Anaesthesiol Scand 2006, 50:1089-1094. 10.1111/j.1399-6576.2006.01138.x, 16987338.
24. Jungheinrich C, Sauermann W, Bepperling F, Vogt NH. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind study. Drugs in R&D 2004, 5:1-9.
25. Hartog C, Brunkhorst FM, Reinhart K. Old versus new starches: what do we know about their differences?. Yearbook of Intensive Care and Emergency Medicine 2009, 233-242. New York: Springer, Vincent J-L.
26. Margetic S. Inflammation and haemostasis. Biochem Med (Zagreb) 2012, 22:49-62.
27. Vancine SM, Picoli-Quaino SK, Costa DS, Montalvao SA, Ozelo MC, Annichino-Bizzacchi JM, De Paula EV. Evaluation of the host response to endotoxemia of FVIII and FIX deficient mice. Haemophilia 2011, 17:800-807.
28. Standl T, Burmeister MA, Schroeder F, Currlin E, Schulte am Esch J, Freitag M, Schulte am Esch J. Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution. Anesth Analg 2003, 96:936-943.
29. Neff TA, Fischler L, Mark M, Stocker R, Reinhart WH. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 2005, 100:1773-1780. 10.1213/01.ANE.0000149326.45137.9A, 15920212.
30. Huter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009, 13:R23. 10.1186/cc7726, 2688141, 19239718.
31. Wittlinger M, Schlapfer M, De Conno E, Z'graggen BR, Reyes L, Booy C, Schimmer RC, Seifert B, Burmeister M-A, Spahn DR, Beck-Schimmer B. The effect of hydroxyethyl starches (HES 130/0.42 and HES 200/0.5) on activated renal tubular epithelial cells. Anesth Analg 2010, 110:531-540. 10.1213/ANE.0b013e3181c03c97, 19910630.
32. Tian J, Lin X, Guan R, Xu J-G. The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 2004, 98:768-774.
33. Nielsen VG, Tan S, Brix AE, Baird MS, Parks DA. Hextend(R) (hetastarch solution) decreases multiple organ injury and xanthine oxidase release after hepatoenteric ischemia-reperfusion in rabbits. Crit Care Med 1997, 25:1565-1574. 10.1097/00003246-199709000-00026, 9295833.
34. Allison KP, Gosling P, Jones S, Pallister I, Porter KM. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma 1999, 47:1114-1121. 10.1097/00005373-199912000-00023, 10608543.
35. Tsai MC, Chen WJ, Ching CH, Chuang JI. Resuscitation with hydroxyethyl starch solution prevents nuclear factor kappa B activation and oxidative stress after hemorrhagic shock and resuscitation in rats. Shock 2007, 27:527-533. 10.1097/01.shk.0000245032.31859.f2, 17438458.
36. Niemi TT, Miyashita R, Yamakage M. Colloid solutions: a clinical update. J Anesth 2010, 24:913-925. 10.1007/s00540-010-1034-y, 20953964.
37. Tian J, Lin X, Li YH, Xu JG. Influence of hydroxyethyl starch on lipopolysaccharide-induced tissue nuclear factor kappa B activation and systemic TNF-alpha expression. Acta Anaesthesiol Scand 2005, 49:1311-1317. 10.1111/j.1399-6576.2005.00849.x, 16146468.
38. Feng XM, Liu J, Yu M, Zhu SH, Xu JG. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage. Anesth Analg 2007, 104:624-630. 10.1213/01.ane.0000250366.48705.96, 17312221.
39. Varga R, Torok L, Szabo A, Kovacs F, Keresztes M, Varga G, Kaszaki J, Boros M. Effects of colloid solutions on ischemia-reperfusion-induced periosteal microcirculatory and inflammatory reactions: Comparison of dextran, gelatin, and hydroxyethyl starch. Crit Care Med 2008, 36:2828-2837. 10.1097/CCM.0b013e318186ff48, 18766091.
40. Handrigan MT, Burns AR, Donnachie EM, Bowden RA. Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration. Shock 2005, 24:434-439. 10.1097/01.shk.0000180625.53800.63, 16247329.
41. Yamamoto N, Unno N, Mitsuoka H, Uchiyama T, Saito T, Konno H. Peritoneal lavage with oxygenated perfluorochemical improves hemodynamics, intestinal injury, and survival in a rat model of severe hemorrhagic shock and resuscitation. Shock 2005, 24:171-176. 10.1097/01.shk.0000168875.91025.b7, 16044089.
42. Ohara M, Unno N, Mitsuoka H, Kaneko H, Nakamura S. Peritoneal lavage with oxygenated perfluorochemical preserves intestinal mucosal barrier function after ischemia-reperfusion and ameliorates lung injury. Crit Care Med 2001, 29:782-788. 10.1097/00003246-200104000-00020, 11373469.
43. Turnage RH, Bagnasco J, Berger J, Guice KS, Oldham KT, Hinshaw DB. Hepatocellular oxidant stress following intestinal ischemia-reperfusion injury. J Surg Res 1991, 51:467-471. 10.1016/0022-4804(91)90166-J, 1943082.
44. Schmeling DJ, Caty MG, Oldham KT, Guice KS, Hinshaw DB. Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery 1989, 106:195-201.
45. Tamion F, Richard V, Lyoumi S, Daveau M, Bonmarchand G, Leroy J, Thuillez C, Lebreton JP. Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am J Physiol 1997, 273:G314-321.
46. Yang R, Han X, Uchiyama T, Watkins SK, Yaguchi A, Delude RL, Fink MP. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 2003, 285:G621-629.
47. Butler F. Fluid resuscitation in tactical combat casualty care: brief history and current status. J Trauma 2011, 70:S11-12.
48. McSwain NE, Champion HR, Fabian TC, Hoyt DB, Wade CE, Eastridge BJ, Proctor KG, Rasmussen TE, Roussel RR, Butler FK, Holcomb JB, Schreiber MA, Shackford SR, Blackbourne LH. State of the art of fluid resuscitation 2010: prehospital and immediate transition to the hospital. J Trauma 2011, 70:S2-10.
49. Rutherford EJ, Morris JA, Reed GW, Hall KS. Base deficit stratifies mortality and determines therapy. J Trauma 1992, 33:417-423. 10.1097/00005373-199209000-00014, 1404512.
50. Rixen D, Raum M, Bouillon B, Lefering R, Neugebauer E. Base deficit development and its prognostic significance in posttrauma critical illness: an analysis by the trauma registry of the Deutsche Gesellschaft fur unfallchirurgie. Shock 2001, 15:83-89.
51. Davis JW, Parks SN, Kaups KL, Gladen HE, O'Donnell-Nicol S. Admission base deficit predicts transfusion requirements and risk of complications. J Trauma 1996, 41:769-774. 10.1097/00005373-199611000-00001, 8913202.
52. Marik P. The optimal endpoint of resuscitation in trauma patients. Crit Care 2003, 7:19-20. 154119, 12617736.
53. Chang MC, Rutherford EJ, Morris JA. Base deficit as a guide to injury severity and volume resuscitation. J Tenn Med Assoc 1993, 86:59-61.
54. Davis JW, Shackford SR, MacKersie RC, Hoyt DB. Base deficit as a guide to volume resuscitation. J Trauma 1988, 28:1464-1467. 10.1097/00005373-198810000-00010, 3172306.
55. Lee CC, Chang IJ, Yen ZS, Hsu CY, Chen SY, Su CP, Chiang WC, Chen SC, Chen WJ. Delayed fluid resuscitation in hemorrhagic shock induces proinflammatory cytokine response. Ann Emergency Med 2007, 49:37-44.
56. Senthil M, Brown M, Xu DZ, Lu Q, Feketeova E, Deitch EA. Gut-lymph hypothesis of systemic inflammatory response syndrome/multiple-organ dysfunction syndrome: validating studies in a porcine model. J Trauma 2006, 60:958-965. 10.1097/01.ta.0000215500.00018.47, 16688055.